Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LY2452473 is an orally bioavailable and selective androgen receptor modulator.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
2 mg | 約 5 days | ¥ 12,000 |
5 mg | 約 5 days | ¥ 20,500 |
10 mg | 約 5 days | ¥ 28,000 |
1 mL * 10 mM (in DMSO) | 約 5 days | ¥ 22,500 |
説明 | LY2452473 is an orally bioavailable and selective androgen receptor modulator. |
In vivo | LY2452473 is being developed for the treatment of disorders related to hypogonadism. LY2452473 is absorbed rapidly (time to reach maximum plasma concentration for both LY2452473 and total radioactivity is 2-3 h) and cleared slowly (plasma terminal t1/2 of 27 h for LY2452473 and 51 h for the total radioactivity). |
分子量 | 374.44 |
分子式 | C22H22N4O2 |
CAS No. | 1029692-15-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 62.5 mg/mL (166.92 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LY2452473 1029692-15-6 MAPK Raf LY-2452473 LY 2452473 Inhibitor inhibitor inhibit